Skip to main content
  • 32 Accesses

Zusammenfassung

Ein Tumor, der aus proliferierenden malignen Spindelzellen besteht, die Osteoid oder Knochensubstanz produzieren.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Uribe-Botero G, Russell WO, Sutow WW, Martin RG (1977) Primary osteosarcoma of bone: a clinicopathologic investigation of 243 cases with necropsy studies in 54. Am J Clin Pathol 67: 4427–4435

    Google Scholar 

  2. Raymond AK, Chawla SP, Carrasco CH, Ayala AG, Fainning CV, Grice B, Armen T, Plager C, Papadopoulos NEJ, Edeiken J, Wallace S, Jaffe N, Murray JA, Benjamin RS (1987) Osteosarcoma chemotherapy effect: a prognostic factor. Sem Diag Path 4: 212–313

    CAS  Google Scholar 

  3. Ayala AG, Ro JY, Fanning CV, Carrasco CH (1990) Needle biopsy of bone lessions. Cancer Bull 42: 305–313

    Google Scholar 

  4. Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of muscopuloskeletal sarcoma. Clin Orthop 153: 106–120

    PubMed  Google Scholar 

  5. Taylor WF, Ivins JC, Unni KK, Beabout JW, Golenzer HJ, Black LE (1989) Prognostic variables in osteosarcoma: a multiinstitutional study. J Natl Cancer Inst 81: 21–30

    Article  PubMed  CAS  Google Scholar 

  6. Grem JL, King SA, Wittes RE, Leyland-Jones B (1988) The role of methotrexate in osteosarcoma. J Natl Cancer Inst 80: 626–655

    Article  PubMed  CAS  Google Scholar 

  7. Cortes EP, Holland JF, Wang JJ, Sinks LF (1973) Chemotherapy of advanced osteosarcoma, Bone: certain aspects of neoplasia; proceedings of the 24th symposium of the Colston Research Society (eds Price and Ross). Butterworths, London, pp 265–280

    Google Scholar 

  8. Jaffe N (1983) Progress in the treatment of osteosarcoma. Clinical Cancer Briefs 5: 3–13

    Google Scholar 

  9. Rosen G, Caparros B, Nirenberg A, Juergens H, Huvos AG (1980) The successful management of metastatic osteogenic sarcoma: a model for the treatment of primary osteogenic sarcoma. Therapeutic Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas (ed van Oosterom AT et al.). Martinus Nijhoff Publishers, The Hague Boston London, pp 349–366

    Chapter  Google Scholar 

  10. Mavligit GM, Benjamin R, Patt YZ, Jaffe N, Cuang V, Wallace S, Murray J, Ayala A, Johnston S, Hersh EM, Calvo II DB (1981) Intraarterial cisplatinum for patients with inoperable skeletal tumors. Cancer 48: 1–4

    Article  PubMed  CAS  Google Scholar 

  11. Marti C, Kroner T, Remagan W, Berchthold W, Cserhati M, Varini M (1985) High-dose ifosfamide in advanced osteosarcoma. Cancer Treat Rep 69: 115–117

    PubMed  CAS  Google Scholar 

  12. Benjamin RS, Baker LH, O’Bryan RM, Moon TE, Gottlieb JA (1978) Chemotherapy for metastatic osteosarcma–studies by the MD Anderson Hospital and the Southwest Oncology Group. Cancer Treat Rep 62: 237–238

    PubMed  CAS  Google Scholar 

  13. Pratt CB, Meyer WH (1987) Response to chemotherapy of patients with metastatic or unresectable osteosarcoma at diagnosis and after failing adjuvant chemotherapy. Proc Am Soc Clin Oncol 6: 214

    Google Scholar 

  14. Morgan E, Baum E, Bleyer A, Movassaghi N, Provisor A, Lampkin B, Lukens S, Sather H, Hammond D (1981) Treatment of relapsed osteogenic sarcoma in children. Proc Am Assoc Cancer Res 22: 399

    Google Scholar 

  15. Mosende C, Gutierrez M, Caparros B, Rosen G (1977) Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma. Cancer 40: 2779–2786

    Article  PubMed  CAS  Google Scholar 

  16. Cortes EP, Holland JF, Glidewell 0 (1978) Amputation and adriamycin in primary osteosarcoma: a 5-year report. Cancer Treat Rep 62: 271–277

    CAS  Google Scholar 

  17. Ryan J, Baker L, Benjamin R, Murphy W, Balcerzak S, Gottlieb J (1990) Long term follow up in the cure of osteogenic sarcoma. Chir Organi Mov LXXV: 48–48

    Google Scholar 

  18. Bleyer WA, Haas JE, Feigl P, Greenlee TK, Schaller RT, Morgan A, Pendergrass TW, Johnson FL, Dernstein ID, Chard RL, Hartman (1982) Improved three-year disease-free survival in osteogenic sarcoma. J Bone and Joint Surgery 64-B: 233–238

    Google Scholar 

  19. Winkler K, Beron G, Schellong G, Stollmann B, Prindull G, Lasson U, Brandeis W, Henze G, Ritter J, Russe W, Stengel-Rutkowski L, Treuner J, Landbeck G (1982) Cooperative osteosarcoma study COSS-77: results after more than 4 years. Klin Paediatr 194: 251–256

    Article  CAS  Google Scholar 

  20. Edmonson JH, Green SJ, Ivins JC, Gilchrist GS, Creagan ET, Pritchard DJ, Smithson WA, Dahlin DC, Taylor WF (1984) A controlled pilot study of highdose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma. J Clin Oncol 2: 152–156

    PubMed  CAS  Google Scholar 

  21. Eilber F, Giuliano A, Eckhardt J, Patterson K, Mosely S, Goodnight J (1987) Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 5: 21–26

    PubMed  CAS  Google Scholar 

  22. Link MP, Goorin AM, Miser AW, Green M, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA, Ayala AG, Shuster JJ, Abelson HT, Simone JV, Vietti TJ (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314: 1600–1602

    Article  PubMed  CAS  Google Scholar 

  23. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C (1982) Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49: 1221–1230

    Google Scholar 

  24. Saeter G, Alvegard A, Elomaa I, Stenwig AE, Holmström T, Solheim OP (1991) Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: A scandinavian sarcoma group study. J Clin Oncol 9: 1766–1775

    Google Scholar 

  25. Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purfürst C, Berger J, Ritter J, Jürgens H, Gerein V, Graf N, Russe W, Gruemayer ER, Ertelt W, Kotz R, Preusser P, Prindull G, Brandeis W, Landbeck G (1988) Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6: 329–337

    PubMed  CAS  Google Scholar 

  26. Jaffe N, Raymond AK, Ayala A Carrasco CH, Wallace S, Robertson R, Griffiths M, Wang Y-M (1987) Effect of escalating courses of intraarterial cis-diamminedichlorplatinum-II on the primary tumor in pediatric osteosarcoma. Proc Am Soc Clin Oncol 6: 217

    Google Scholar 

  27. Winkler K, Bielack S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw C, Jürgens H, Ritter J, Kusnierz-Glaz C, Erttmann R, Gädicke G, Graf N, Ladenstein R, Leyvraz S, Mertens R, Weinel P (1990) Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (Study COSS-86). Cancer 66: 1703–1710

    Article  PubMed  CAS  Google Scholar 

  28. Bacci G, Picci P, Gherlinzoni F, Horn JR van, Orlandi M, Normand R, Manfrini M, Pignatti G, Campanacci M (1986) Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? Chemioterapia 5: 140–143

    PubMed  CAS  Google Scholar 

  29. Benjamin RS, Chawla SP, Carrasco CH, Raymond AK, Murray JA, Armen TO, Wallace S, Ayala A, Papadopoulos NEJ, Plager C, Romsdahl MM, Martin RG (1990) Primary chemotherapy for osteosarcoma with systemic adriamycin and intra-arterial cisplatin. Cancer Bull 42: 314–317

    Google Scholar 

  30. Bramwell VHC, Burgers M, Sneath R, Souhami R, Oosterom AT van, Voute PA, Rouesse J, Spooner D, Craft AW, Somers R, Pringle J, Malcolm AJ, Eijken J, Thomas D, Uscinska B, Machin D, Glabbeke M van (1992) A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study of the European Osteosarcoma Intergroup. J Clin Oncol 10: 1579–1591

    Google Scholar 

  31. Salem PA, Benjamin RS, Howard J, Gutterman JU (1991) Phase II trial of recombination interferon alpha 2-b in the treatment of advanced metastatic and refractory sarcoma. Proc Am Assoc Cancer Res 32: 200

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Patel, S.R., Benjamin, R.S. (1993). Osteosarkom. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10495-8_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56872-8

  • Online ISBN: 978-3-662-10495-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics